Will Agomab Therapeutics NV's market cap be between $600M and $700M at market close on IPO day?

This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before April 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day. If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket. Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used. In the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.